Emapalumab Treatment For Anticipated Clinical Benefit In Sepsis Driven By The Interferon-Gamma Endotype (The EMBRACE Trial)
Clinical trial NCT06694701 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06694701
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-22
- Primary completion
- 2026-11-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.